19 Nedsat nyrefunktion I et oralt enkeltdosisstudie (200 mg) hos patienter med normal nyrefunktion og mild (kreatinin clearance 41- 60 ml/ min) til svært nedsat nyrefunktion (kreatinin clearance < 20 ml/ min) var voriconazols farmakokinetik ikke signifikant påvirket af nedsat nyrefunktion.
19 Renal impairment In an oral single dose (200 mg) study in subjects with normal renal function and mild (creatinine clearance 41-60 ml/ min) to severe (creatinine clearance < 20 ml/ min) renal impairment, the pharmacokinetics of voriconazole were not significantly affected by renal impairment.